Join the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationEMA - Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 May 2022
EMA - Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 May 2022
From the EMA Stakeholder engagement biennial report 2020-2021 and highlights of stakeholder activities in 2021 We are pleased to inform you that the biennial stakeholder engagement report has been published, along with the highlights of stakeholder activities in 2021. This report provides a high-level overview of EMA's engagement with patients, consumers, healthcare professionals and academia and different activities where they have been involved. EMA would like to thank all stakeholders involved in activities during these two challenging years. This biennial report has also been shared by social media, the links are below:
MHRA: policy for handling conflicts of interest - Uploaded the annual conflict of interest compliance report - 2021
MHRA - Uploaded the Drug Safety Update for May 2022
WHO launches first ever global report on infection prevention and control
Compliance Monitor Process (Part 2)– CM role and application process - a new blog post from the MHRA.
EMA - CTIS newsflash #11 - 22 April 2022
EMA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 April 2022
EMA have provided an overview of comments received between December 2021 and March 2022 on on ICH guideline Q9 (R1) on quality risk management.